In the News

1852 News Items found
Memorial Sloan Kettering Cancer Center (MSK) today celebrates its 26th year of the "holiday hallway." Each year during December, MSK’s carpenters, toolmakers, locksmiths, electricians, and painters construct a winter wonderland in the basement hallway of MSK for patients, families, and staff to visit and enjoy. The decades-long tradition brings joy and cheer to all and has grown in size and detail year after year. The “holiday hallway” is a labor of love for MSK’s Facilities staff, who give of themselves to create the magical MSK tradition. 
Memorial Sloan Kettering medical oncologist Eileen O’Reilly
In the News
As we approach the end of 2019, learn about some of the biggest advances in clinical research made this year at MSK.
Illustration of breast cancer cell
In the Clinic
MSK medical oncologist Shanu Modi is the lead author of a new paper detailing the results from a phase II trial of a breast cancer drug called trastuzumab deruxtecan or DS-8201a. Results from this study were also presented at the San Antonio Breast Cancer Symposium.
The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center will be home to the largest gathering of hematologic experts ever at Memorial Sloan Kettering Cancer Center (MSK), including specialists in blood and marrow stem cell transplants, chimeric antigen receptor T cell therapy, lymphoma, leukemia, multiple myeloma, and nonmalignant blood disorders.
The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center sets a new benchmark for sustainability and resiliency in a healthcare facility.
Micrograph of multiple myeloma cells
In the News
Two studies on multiple myeloma provide new information about diagnosing and treating this blood cancer.
Exterior shot of building at ASH meeting
In the News
Learn more about the work of MSK lymphoma researchers being presented at the 2019 meeting of the American Society of Hematology.
After years of planning and anticipation, the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is scheduled to open in January 2020.
MSK patient playing with child life therapist
Feature
Discover how MSK Kids is using medical play to help children understand treatments and procedures.
Two images of a human torso show a reduction in tumors after treatment with targeted therapy.
Finding
In an international study led by MSK, researchers reported finding key mutations driving the disease histiocytosis for nearly all of the people included.